Compugen and Merck Serono to Collaborate on Novel Peptide|Nov 26, 2008
CGEN 855 Targets the FPRL1 G-protein Coupled Receptor
Compugen Reports Third Quarter 2008 Financial Results|Nov 13, 2008
End of Year CEO Retirement and Company 2009 Plans Announced Yesterday